Model
Edge
Janux Therapeutics
0001864159
Filing Type
4
Filing Date
1/1/2026
Updated
1/2/26, 7:00 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership